v3.26.1
Business Segment Information - Additional Information (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
segment
Jun. 30, 2025
USD ($)
Segment Reporting [Line Items]        
Reportable segments | segment     2  
Gain from equity investment   $ 39,700   $ 39,700
Gain on remeasurement   27,300   30,600
Currency remeasurement gain   $ 26,000   15,700
Loss on divestiture     $ (17,247) $ 35,539
OneOncology        
Segment Reporting [Line Items]        
Remeasurement gain related to OneOncology acquisition     1,100,000  
Segment Reconciling Items | Distribution of prescription opioid medications        
Segment Reporting [Line Items]        
Accrual adjustments $ 102,000   102,000  
Settlement accrual reduction     $ 86,800